Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 2375564-55-7 Chemical Structure| 2375564-55-7

Structure of ACBI1
CAS No.: 2375564-55-7

Chemical Structure| 2375564-55-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ACBI1 is an effective PROTAC-based degrader of BAF ATPase subunits SMARCA2 and SMARCA4, as well as PBRM1, a member of the PBAF complex. It exhibits anticancer activity and apoptosis induction with DC50 values of 6 nM for SMARCA2, 11 nM for SMARCA4, and 32 nM for PBRM1.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of ACBI1

CAS No. :2375564-55-7
Formula : C49H58FN9O7S
M.W : 936.10
SMILES Code : CC(N=CS1)=C1C2=CC=C(CNC([C@@H]3C[C@@H](O)CN3C([C@H](C(C)(C)C)NC(C4(CC4)F)=O)=O)=O)C(OCCOC5=CC=C(CN6CCN(C7=CC(C8=C(O)C=CC=C8)=NN=C7N)CC6)C=C5)=C2
MDL No. :MFCD32689497

Safety of ACBI1

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H314
Precautionary Statements:P264-P270-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P310-P330-P331-P363-P403+P233-P501
Class:8
UN#:3261
Packing Group:

Related Pathways of ACBI1

epigenetics

Isoform Comparison

Biological Activity

Description
ACBI1 is a potent and synergistic degrader of SMARCA2, SMARCA4, and PBRM1 with DC50 values of 6, 11, and 32 nM, respectively. It functions as a PROTAC degrader, exhibiting anti-proliferative activity and inducing apoptosis[1].

In Vitro:

Cell Line
Concentration Treated Time Description References
MV-4-11 cells 11 nM 18 h Degradation of PBRM1 PMC6600871
MV-4-11 cells 6 nM 18 h Degradation of PBRM1 PMC6600871
Rh30 200 nM 24-48 hours To evaluate the effect of ACBI1 on PBRM1 protein expression PMC9985831
IdHPCs 1 μM 4 days Degrade BRG1, partially restore nucleosome density PMC9705430
NCI-H1568 cells 15.6 nM 18 h Degradation of PBRM1 PMC6600871
NCI-H1568 cells 3.3 nM 18 h Degradation of PBRM1 PMC6600871
MV-4-11 cells 32 nM 18 h Degradation of PBRM1 PMC6600871
Calu-3 cells 2.5 μM 48 hours To evaluate the effect of ACBI1 on SARS-CoV-2 infection, results showed that ACBI1 significantly inhibited viral replication. PMC10011139
Huh7.5 cells 2.5 μM 48 hours To evaluate the effect of ACBI1 on SARS-CoV-2 infection, results showed that ACBI1 significantly inhibited viral replication. PMC10011139
Vero E6 cells 2.5 μM 48 hours To evaluate the effect of ACBI1 on SARS-CoV-2 infection, results showed that ACBI1 significantly inhibited viral replication. PMC10011139
HEK293T cells 500 nM 72 hours To evaluate the effect of ACBI1 on SMARCA4 protein levels in HEK293T cells, results showed that ACBI1 treatment led to a reduction in SMARCA4 protein levels. PMC10643139
HS-SY-II cells 500 nM 72 hours To evaluate the effect of ACBI1 on SMARCA4 protein levels in HS-SY-II cells, results showed that ACBI1 treatment led to a reduction in SMARCA4 protein levels. PMC10643139
G401 cells 250 nM 1 hour to 24 hours To evaluate the effect of ACBI1 on BRG1 and PBRM1 protein levels, results showed that ACBI1 rapidly reduced BRG1 and PBRM1 levels. PMC9160003

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice SARS-CoV-2/MA10 infection model Intraperitoneal injection 25 mg/kg Once daily for 4 days To evaluate the effect of ACBI1 on SARS-CoV-2 infection, results showed that ACBI1 did not significantly inhibit viral replication in the mouse model. PMC10011139
SHO mice ARMS xenograft model Pretreated cell injection 50 nM 3 days pretreatment To evaluate the effect of ACBI1 on tumor growth PMC9985831
Mouse ERT2-Cre:Pcgf1fl/fl mice Intraperitoneal injection Induced at 4 weeks post-transplantation, analyzed at 8 weeks post-treatment Study the effect of PCGF1 deletion on hematopoietic stem cell differentiation PMC9705430

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.07mL

0.21mL

0.11mL

5.34mL

1.07mL

0.53mL

10.68mL

2.14mL

1.07mL

References

 

Historical Records

Categories